Denosumab

Amber

Brand Name(s):Prolia

Indication:Osteoporosis (prevention) in postmenopausal women at increased risk of fractures. Men with increase risk of fracture

Rationale:1,2,3,8

Considered:Nov-11

Review Date:Jun-22

Comments:
Drug Safety Update
Denosumab is associated with a risk of osteonecrosis of the jaw, osteonecrosis of the external auditory canal has also been reported with denosumab
June 2017